Theratechnologies Inc. (TSE:TH – Get Free Report)’s stock price crossed below its 50 day moving average during trading on Monday . The stock has a 50 day moving average of C$4.50 and traded as low as C$4.36. Theratechnologies shares last traded at C$4.47, with a volume of 35,472 shares changing hands.
Analysts Set New Price Targets
Separately, Jones Trading downgraded Theratechnologies from a “strong-buy” rating to a “hold” rating in a research report on Thursday, July 3rd. One research analyst has rated the stock with a Strong Buy rating and one has given a Hold rating to the stock. According to MarketBeat.com, the stock presently has a consensus rating of “Buy”.
Theratechnologies Price Performance
About Theratechnologies
Theratechnologies Inc is a specialty pharmaceutical company that addresses the unmet medical needs of HIV patients. It mainly operates in Canada and the United States. The company has two approved products, EGRIFTA marketed in Canada and the United States, and Trogarzo approved for commercialization in the United States.
Featured Articles
- Five stocks we like better than Theratechnologies
- How Investors Can Find the Best Cheap Dividend Stocks
- Growth Picks: 3 Low-Cost Stocks That Could Double in Value
- 3 Stocks to Consider Buying in October
- Are These 3 Beaten-Down Stocks Ready to Rebound?
- 3 Must-Buy Warren Buffett Stocks for Volatile Times
- Does the Trump-Induced Quantum Stock Rally Have Legs?
Receive News & Ratings for Theratechnologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Theratechnologies and related companies with MarketBeat.com's FREE daily email newsletter.
